CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia. Mehta J. N Engl J Med 2021;384:e91.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mehta J. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and beta-Thalassemia. N Engl J Med 2021;384:e91.
PMID: 34107196